je.st
news
Home
› BioCryst to Present Peramivir Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting
BioCryst to Present Peramivir Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting
2014-09-02 15:31:04| Biotech - Topix.net
BioCryst Pharmaceuticals, Inc. today announced the presentation of trial results related to intravenous peramivir for the treatment of influenza at the Interscience Conference on Antimicrobial Agents & Chemotherapy in Washington, D.C., September 5-9, 2014.
Tags: the
results
present
meeting
Category:Biotechnology and Pharmaceuticals